Dr. Gowriharan Thaiyananthan, founder and head surgeon of the Brain and Spine Institute of California in Orange County, is one of the first surgeons in the U.S. to utilize inSRT to treat spine disease, according to a news release by Dr. Thaiyananthan.
Dr. Thaiyananthan co-developed inSRT, a cryopreserved fetal stem cell matrix, to use during The Spinal Renewal Treatment, which is a minimally invasive procedure that takes around an hour to complete. The treatment may treat degenerative disc disease, spinal stenosis and scoliosis.
The Spinal Renewal Treatment may be best suited for sufferers of chronic neck and back pain, individuals who have undergone spinal surgery and those who suffer from weakness due to spinal cord compression. The matrix is derived from fetal after birth cells that include residual proteins, carbohydrates, hyaluronic acid and other chemicals naturally present in amniotic fluid and tissue essential for fetal growth and development. The undifferentiated cells have unique anti-inflammatory properties to help regenerate cells and relive pain.
Dr. Thaiyananthan is co-medical director at the Southern California Center for Neuroscience and Spine at Chapman Medical Center in Orange, Calif. He earned his medical degree from the University of California, San Francisco. Dr. Thaiyananthan completed a surgical internship and neurosurgery residency at Yale New Haven Hospital and a combined neurosurgery/orthopedic fellowship at Cedars-Sinai in Los Angeles. Follow Dr. Ty on Google+.
Sign up for our FREE Spine E-Weekly for more coverage like this sent to your inbox!
Related Articles on Spinal Treatments:
NLT Spine Receives FDA Clearance for Minimally Invasive TLIF System
Which Spine Procedures Are Difficult to Receive Reimbursement For?
Study: Spinal Fusions for Rett Syndrome Risk Postoperative Complications
The Spinal Renewal Treatment may be best suited for sufferers of chronic neck and back pain, individuals who have undergone spinal surgery and those who suffer from weakness due to spinal cord compression. The matrix is derived from fetal after birth cells that include residual proteins, carbohydrates, hyaluronic acid and other chemicals naturally present in amniotic fluid and tissue essential for fetal growth and development. The undifferentiated cells have unique anti-inflammatory properties to help regenerate cells and relive pain.
Dr. Thaiyananthan is co-medical director at the Southern California Center for Neuroscience and Spine at Chapman Medical Center in Orange, Calif. He earned his medical degree from the University of California, San Francisco. Dr. Thaiyananthan completed a surgical internship and neurosurgery residency at Yale New Haven Hospital and a combined neurosurgery/orthopedic fellowship at Cedars-Sinai in Los Angeles. Follow Dr. Ty on Google+.
Sign up for our FREE Spine E-Weekly for more coverage like this sent to your inbox!
Related Articles on Spinal Treatments:
NLT Spine Receives FDA Clearance for Minimally Invasive TLIF System
Which Spine Procedures Are Difficult to Receive Reimbursement For?
Study: Spinal Fusions for Rett Syndrome Risk Postoperative Complications